Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: A systematic review.

doi:10.1016/j.nutres.2018.04.003

Paper

Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: A systematic review.

Published Aug 1, 2018 · Vahid Maleki, Azimeh Izadi, Alireza Farsad-Naeimi

Nutrition research

Q2 SJR score

13

Citations

0

Influential Citations

Full text

Semantic Scholar

Abstract

Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Systematic Review

Study Snapshot

Key takeawayChromium supplementation has limited effects on weight reduction, glucose control, lipid profile, and hormonal disturbances in women with polycystic ovary syndrome.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Chromium supplementation does not improve weight loss or metabolic and hormonal variables in patients with polycystic ovary syndrome: A systematic review.

References

Citations